The newborn screening market is segmented on the basis of test type, product and technology. On test type basis the market is further segmented into dry blood spot test, critical congenital heart disease and hearing screen test. The dry blood spot test market shares the highest market owing to sample stability and reliable results. For instance, Recent FDA’s review included a study of approximately 6,400 blood spot specimens from routine screening of newborns, 17 of which had tested SCID positive.
http://www.grandviewresearch.com/industry-analysis/newborn-screening-market
No comments:
Post a Comment